The World Health Organization has raised the public-health risk assessment for the Bundibugyo strain of Ebola in the Democratic Republic of Congo to "very high" [1].
This escalation follows the rapid spread of the virus across conflict-affected regions where containment is difficult. Because the Bundibugyo strain lacks approved vaccines or treatments, the risk of uncontrolled transmission and high fatality rates is significant.
Health officials first confirmed the outbreak on May 15, 2026 [2]. The virus initially appeared in the Ituri province of eastern DRC, but it has since spread to South Kivu and North Kivu [1]. The outbreak has also crossed international borders, with three locally transmitted cases reported in neighboring Uganda [3].
The Bundibugyo strain is particularly lethal, with a mortality rate ranging from 30 to 50 percent [1]. The WHO said that the spread is occurring in areas heavily impacted by conflict, which complicates the delivery of medical aid and the implementation of quarantine measures.
While the WHO has raised the risk level to "very high" [1], other reports from UN News said the risk remains high for regional spread while remaining low at global levels [1]. Despite these differing assessments of the scale, the lack of medical countermeasures remains a critical vulnerability for the affected populations in the DRC and Uganda.
“The Bundibugyo strain has a mortality rate of 30–50 percent.”
The upgrade to a 'very high' risk level signals that the outbreak is outpacing current containment efforts. The combination of a high mortality rate, the absence of a vaccine, and the instability of conflict zones in eastern DRC creates a scenario where the virus can spread undetected and untreated, increasing the likelihood of a regional epidemic.
